News
While some practices lower the risk for complications with peripherally inserted central catheters, evidence gaps highlight ...
Yet current clot-removal tools succeed on the first try only about 50 percent of the time. In 15 percent of cases, they fail completely. For tough, fibrin-rich clots, success rates drop to as low ...
On Friday, the FDA classified a recall of Inari Medical Inc’s (NASDAQ:NARI) ClotTriever catheter as “most serious.” The ClotTriever XL Catheter is used to remove clots (thrombi) and ...
The FDA designated Inari Medical’s recall of its catheter for clot removal in large blood vessels as class I. Image: Adobe Stock. Labeling changes include updates to the device warnings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results